This information is intended for Healthcare Professionals
You will now be re-directed to www.pfizermedicalinformation.com
View studies/programs by
PROTAC Estrogen Receptor DegraderCDK4 Inhibitor
CDK4 Inhibitor
CDK2 InhibitorCDK4 Inhibitor
HER2-directed Antibody Drug Conjugate
PROTAC Estrogen Receptor DegraderCDK4/6 Inhibitor
CDK4/6 Inhibitor
KAT6 A/B Inhibitor
CDK2 Inhibitor
HER2 Tyrosine Kinase inhibitor
PROTAC Estrogen Receptor Degrader
BRAF Inhibitor
PF-08634404 (SSGJ-707)
Nectin-4-directed Antibody Drug Conjugate
PF-08052667 | B6N
EZH2 Inhibitor
Anti-PD-1 Monoclonal Antibody (mAb)
PARP Inhibitor
TF-directed Antibody Drug Conjugate
CD30-directed Antibody Drug Conjugate
BCMA-CD3 Bispecific Antibody
PF-08046040
BRAF InhibitorMEK Inhibitor
PF-08046050
BRAFi
PDL1V | PD-L1-directed Antibody Drug Conjugate
PF-08032562 | KAT6/7
PF-08046876 | B6C
PF-07934040
PF-08052666
MEK Brain Penetrant Inhibitor
GDF-15 Monoclonal Antibody
GDF-15 Monocolonal Antibody
Integrin beta-6 directed Antibody Drug Conjugate
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecological Cancer
Hematologic Malignancies
Melanoma
Other or Multiple Cancer Types
Thoracic Cancer